|
FY2025
12 months to Jan 31, 2026
|
FY2024
12 months to Feb 1, 2025
|
FY2023
12 months to Feb 3, 2024
|
FY2022
12 months to Jan 28, 2023
|
FY2021
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Loss from retirement plan terminations | |||||
| Amortization and write-off of deferred debt issuance costs | |||||
| Impairment of assets | |||||
| Depreciation and amortization | |||||
| Gain on sale of equipment | |||||
| Deferred taxes, net of valuation allowance | |||||
| Stock compensation expense | |||||
| Board of directors' stock compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Operating leases, net | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Additions to property and equipment, net | |||||
| Proceeds from sale of equipment | |||||
| Purchase of short-term investments | |||||
| Maturity of short-term investments | |||||
| Net cash provided by (used for) investing activities | |||||
| Cash flows from financing activities: | |||||
| Payment of debt issuance costs | |||||
| Repurchase of common stock | |||||
| Payment of excise tax on repurchased shares of common stock | |||||
| Proceeds from the exercise of stock options | |||||
| Tax withholdings paid related to net share settlements | |||||
| Net cash used for financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents: | |||||
| Beginning of period | |||||
| End of period | |||||
Loading...